Role of 18F-FDG PET in the diagnosis of Rasmussen's disease.
Departamento de Medicina Nuclear, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain. migue8a@hotmail.com
M A
MA
Ochoa-Figueroa
C
C
Cárdenas-Negro
A
A
Allende-Riera
E
E
Martínez-Gimeno
M
M
Desequera-Rahola
J
J
Uña-Gorospe
D000927:Anticonvulsants / Q000627:therapeutic use; D002675:Child, Preschool; D018450:Disease Progression; D004569:Electroencephalography; D004660:Encephalitis / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000601:surgery; D005260:Female; D019788:Fluorodeoxyglucose F18; D038421:Hemispherectomy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D010291:Paresis / Q000209:etiology; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D013226:Status Epilepticus / Q000188:drug therapy / Q000209:etiology / Q000601:surgery
D000927:Anticonvulsants; D007166:Immunosuppressive Agents; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18